Overview
CTVA market data
Price History
CTVA price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for CTVA. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Oppenheimer Maintains Outperform on Corteva, Raises Price Target to $95Benzinga · Jul 23, 2026, 2:39 PM
RBC Capital Maintains Outperform on Corteva, Raises Price Target to $103Benzinga · Jul 21, 2026, 4:05 PM
B of A Securities Maintains Buy on Corteva, Raises Price Target to $96Benzinga · Jul 20, 2026, 5:44 PM
Mizuho Maintains Outperform on Corteva, Raises Price Target to $97Benzinga · Jul 14, 2026, 12:33 PM
New York Attorney General's Suit Names 3M, Chemours, Corteva, DuPont De Nemours; New York Attorney General Sues Chemical Companies Over Alleged Toxic Pollution from Consumer ProductsBenzinga · Jul 9, 2026, 3:45 PM
This Senator Just Bought Up To $15K In AT&T StockBenzinga · Jul 3, 2026, 3:05 PM
Mizuho Maintains Outperform on Corteva, Raises Price Target to $96Benzinga · Jul 2, 2026, 1:50 PM
8-K filing — Corteva, Inc. (CTVA)SEC EDGAR · Jun 29, 2026, 9:23 PM
Corteva Names Greg Page As Independent ChairBenzinga · Jun 29, 2026, 8:40 PM
Corteva Planned Seed And Genetics Spin-Off Targeted For Q4 2026Benzinga · Jun 29, 2026, 8:40 PM